1
|
Duley L: The global impact of
pre-eclampsia and eclampsia. Semin Perinatol. 33:130–137. 2009.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Redman CW and Sargent IL: Preeclampsia and
the systemic inflammatory response. Semin Nephrol. 24:565–570.
2004. View Article : Google Scholar : PubMed/NCBI
|
3
|
Pineles BL, Romero R, Montenegro D, Tarca
AL, Han YM, Kim YM, Draghici S, Espinoza J, Kusanovic JP, Mittal P,
et al: Distinct subsets of microRNAs are expressed differentially
in the human placentas of patients with preeclampsia. Am J Obstet
Gynecol. 196:261.e1–6. 2007. View Article : Google Scholar
|
4
|
Zhu XM, Han T, Sargent IL, Yin GW and Yao
YQ: Differential expression profile of microRNAs in human placentas
from preeclamptic pregnancies vs normal pregnancies. Am J Obstet
Gynecol. 200:661.e1–7. 2009. View Article : Google Scholar
|
5
|
Hu Y, Li P, Hao S, Liu L, Zhao J and Hou
Y: Differential expression of microRNAs in the placentae of Chinese
patients with severe pre-eclampsia. Clin Chem Lab Med. 47:923–929.
2009. View Article : Google Scholar : PubMed/NCBI
|
6
|
Enquobahrie DA, Abetew DF, Sorensen TK,
Willoughby D, Chidambaram K and Williams MA: Placental microRNA
expression in pregnancies complicated by preeclampsia. Am J Obstet
Gynecol. 204:178. e12–21. 2011. View Article : Google Scholar
|
7
|
Ji L, Brkić J, Liu M, Fu G, Peng C and
Wang YL: Placental trophoblast cell differentiation: Physiological
regulation and pathological relevance to preeclampsia. Mol Aspects
Med. 34:981–1023. 2013. View Article : Google Scholar : PubMed/NCBI
|
8
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008. View Article : Google Scholar : PubMed/NCBI
|
9
|
Noack F, Ribbat-Idel J, Thorns C, Chiriac
A, Axt-Fliedner R, Diedrich K and Feller AC: miRNA expression
profiling in formalin-fixed and paraffin-embedded placental tissue
samples from pregnancies with severe preeclampsia. J Perinat Med.
39:267–271. 2011. View Article : Google Scholar : PubMed/NCBI
|
10
|
Betoni JS, Derr K, Pahl MC, Rogers L,
Muller CL, Packard E, Carey DJ, Kuivaniemi H and Tromp G: MicroRNA
analysis in placentas from patients with preeclampsia: Comparison
of new and published results. Hypertens Pregnancy. 32:321–339.
2013. View Article : Google Scholar : PubMed/NCBI
|
11
|
Hromadnikova I, Kotlabova K, Ondrackova M,
Kestlerova A, Novotna V, Hympanova L, Doucha J and Krofta L:
Circulating C19MC microRNAs in preeclampsia, gestational
hypertension, and fetal growth restriction. Mediators Inflamm.
2013:1860412013. View Article : Google Scholar : PubMed/NCBI
|
12
|
Gunel T, Zeybek YG, Akçakaya P, Kalelioğlu
I, Benian A, Ermis H and Aydınlı K: Serum microRNA expression in
pregnancies with preeclampsia. Genet Mol Res. 10:4034–4040. 2011.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Hromadnikova I, Kotlabova K, Doucha J,
Dlouha K and Krofta L: Absolute and relative quantification of
placenta-specific micrornas in maternal circulation with placental
insufficiency-related complications. J Mol Diagn. 14:160–167. 2012.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Yang Q, Lu J, Wang S, Li H, Ge Q and Lu Z:
Application of next-generation sequencing technology to profile the
circulating microRNAs in the serum of preeclampsia versus normal
pregnant women. Clin Chim Acta. 412:2167–2173. 2011. View Article : Google Scholar : PubMed/NCBI
|
15
|
Zhang Y, Fei M, Xue G, Zhou Q, Jia Y, Li
L, Xin H and Sun S: Elevated levels of hypoxia-inducible
microRNA-210 in pre-eclampsia: New insights into molecular
mechanisms for the disease. J Cell Mol Med. 16:249–259. 2012.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Xu P, Zhao Y, Liu M, Wang Y, Wang H, Li
YX, Zhu X, Yao Y, Wang H, Qiao J, et al: Variations of microRNAs in
human placentas and plasma from preeclamptic pregnancy.
Hypertension. 63:1276–1284. 2014. View Article : Google Scholar : PubMed/NCBI
|
17
|
Ishibashi O, Ohkuchi A, Ali MM, Kurashina
R, Luo SS, Ishikawa T, Takizawa T, Hirashima C, Takahashi K, Migita
M, et al: Hydroxysteroid (17-β) dehydrogenase 1 is dysregulated by
miR-210 and miR-518c that are aberrantly expressed in preeclamptic
placentas: A novel marker for predicting preeclampsia.
Hypertension. 59:265–273. 2012. View Article : Google Scholar : PubMed/NCBI
|
18
|
Tan Z, Randall G, Fan J, Camoretti-Mercado
B, Brockman-Schneider R, Pan L, Solway J, Gern JE, Lemanske RF,
Nicolae D, et al: Allele-specific targeting of microRNAs to HLA-G
and risk of asthma. Am J Hum Genet. 81:829–834. 2007. View Article : Google Scholar : PubMed/NCBI
|
19
|
Yie SM, Li LH, Li YM and Librach C: HLA-G
protein concentrations in maternal serum and placental tissue are
decreased in preeclampsia. Am J Obstet Gynecol. 191:525–529. 2004.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Heazell AE and Crocker IP: Live and let
die-regulation of villous trophoblast apoptosis in normal and
abnormal pregnancies. Placenta. 29:772–783. 2008. View Article : Google Scholar : PubMed/NCBI
|
21
|
Smith GC and Wear H: The perinatal
implications of angiogenic factors. Curr Opin Obstet Gynecol.
21:111–116. 2009. View Article : Google Scholar : PubMed/NCBI
|
22
|
Zhang QH, Sun HM, Zheng RZ, Li YC, Zhang
Q, Cheng P, Tang ZH and Huang F: Meta-analysis of microRNA-183
family expression in human cancer studies comparing cancer tissues
with noncancerous tissues. Gene. 527:26–32. 2013. View Article : Google Scholar : PubMed/NCBI
|
23
|
Shi XY, Gu L, Chen J, Guo XR and Shi YL:
Downregulation of miR-183 inhibits apoptosis and enhances the
invasive potential of endometrial stromal cells in endometriosis.
Int J Mol Med. 33:59–67. 2014.PubMed/NCBI
|
24
|
Wu L, Zhou H, Lin H, Qi J, Zhu C, Gao Z
and Wang H: Circulating microRNAs are elevated in plasma from
severe preeclamptic pregnancies. Reproduction. 143:389–397. 2012.
View Article : Google Scholar : PubMed/NCBI
|